Headache & Migraine
Literature Review
Largest ever review of new daily persistent headache assesses its clinical features
“Future prospective studies are needed to better understand this disabling disorder.”
Conference Coverage
Patients given NSAIDs over antiemetics for headaches spend less time in the ED
Treatment with oral drugs only was associated with an 11% reduction of length of stay, compared with treatment with parenteral medication only.
Conference Coverage
DIY nerve stimulation effective in episodic migraine
Participants in a new study applied neurostimulation for a continuous 2-hour period within 4 hours of a migraine attack.
From the Journals
New antimigraine drugs linked with less risk for adverse events
The safety and efficacy of new antimigraine treatments were compared with current standard therapy, in a new systematic review.
Conference Coverage
Pandemic survey: Forty-six percent of pediatric headache patients got worse
But some fared better when they were stuck at home instead of at school.
Conference Coverage
Migraine history linked to more severe hot flashes in postmenopausal women
Researchers suspect the association between vasomotor symptoms and migraine could result from a common cause in neurovascular dysregulation, but...
FDA/CDC
FDA okays new oral CGRP antagonist for migraine prevention
With this approval, neurologists will be able to choose from four monoclonal antibodies and two gepants for the preventive treatment of migraine...
From the Journals
Assessing headache severity via migraine symptoms can help predict outcomes
“Our hope is that this work serves as foundational basis for better understanding the complexity of headache as a symptom-based condition.”
From the Journals
Atogepant reduces migraine days: ADVANCE trial results published
“Overall, this study showed us that atogepant was safe and surprisingly seems to be pretty effective regardless of the dose.”
From the Journals
Headache seen affecting some pregnancy outcomes
A new study links migraine – and also tension-type headache – to small-for-gestational-age babies.
Literature Review
Trial finds that intranasal DHE is well tolerated and may reduce migraine symptoms
Most patients experienced symptom relief within 2 hours and reported that the medication was easy to use and preferable to their current therapy...